CytoMed Therapeutics GDTC
NASDAQ GDTC
$0.91 +0.00 (+0.00%)
As of: Oct 22, 2026 · 3:59 PM EDT

CytoMed Therapeutics (GDTC) Research & Development (2022 - 2026)

Updated

CytoMed Therapeutics (GDTC) posted Research & Development of $310,842 for Q2 2026, up 9.6% from $283,559 a year earlier.

Analysis

CytoMed Therapeutics (GDTC) Research & Development (2022 - 2026) Analysis & Trends

For FY2025, CytoMed Therapeutics' Research & Development came in at -$2.22 million.

  • In prior years, CytoMed Therapeutics' Research & Development was -$1.91 million in FY2024, -$1.59 million in FY2023, -$1.52 million in FY2022 and -$1.09 million in FY2021.
  • The Q2 2026 figure stands as the highest quarterly Research & Development since Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 3.82 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 4.65 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 2.34 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 9.74 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 2.85 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 4.05 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 1.87 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 1.76 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 2.81 Bn
10 CytoMed Therapeutics 10.46 Mn 855,548.76 - 310,842.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 310,842.00
Jun 30, 2025 283,559.00
Jun 30, 2024 239,805.00
Jun 30, 2023 811,319.00
Jun 30, 2022 604,043.00
API Access

CytoMed Therapeutics Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=GDTC&period=max&api_key=YOUR_API_KEY